Enanta Pharmaceuticals, Inc. (ENTA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 178.41M | 198.68M | 204.34M | 222.71M | 242.86M | 268.14M | 299.85M | 286.58M | 351.03M | 390.3M | 422.79M | 448.46M |
| Cash & Short-Term Investments | 163.77M | 185.85M | 188.86M | 204.11M | 193.38M | 216.69M | 248.19M | 230.09M | 300.31M | 337.15M | 369.91M | 386.58M |
| Cash Only | 34.93M | 37.44M | 32.3M | 44.81M | 60.21M | 84.35M | 37.23M | 35.77M | 63.54M | 39.93M | 85.39M | 95.18M |
| Short-Term Investments | 128.85M | 148.41M | 156.57M | 159.3M | 133.16M | 132.34M | 210.95M | 194.31M | 236.77M | 297.22M | 284.52M | 291.41M |
| Accounts Receivable | 7.83M | 8.49M | 6.88M | 8.36M | 40.63M | 40.16M | 38.65M | 40.63M | 39.79M | 39.91M | 39.62M | 18.89M |
| Days Sales Outstanding | 42.8 | 37.99 | 46.35 | 121.7 | 243.57 | 213.76 | 249.65 | 203.61 | 212.62 | 203.2 | 142.16 | 88.36 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 6.81M | 4.34M | 8.59M | 10.24M | 8.86M | 11.29M | 13.02M | 15.87M | 10.93M | 13.24M | 13.26M | 25.92M |
| Total Non-Current Assets | 136.29M | 130.82M | 76.4M | 78.32M | 80.13M | 80.5M | 76.8M | 112.24M | 62.53M | 38.2M | 39.48M | 46.7M |
| Property, Plant & Equipment | 69.55M | 71.31M | 72.94M | 74.87M | 76.67M | 77.04M | 73.35M | 66.26M | 58.37M | 33.46M | 34.71M | 35.98M |
| Fixed Asset Turnover | 0.24x | 0.26x | 0.20x | 0.24x | 0.19x | 0.23x | 0.21x | 0.29x | 0.37x | 0.53x | 0.54x | 0.53x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 66.6M | 56.05M | 3.36M | 3.36M | 0 | 0 | 0 | 42.51M | 3.97M | 0 | 0 | 5.92M |
| Other Non-Current Assets | 144K | 3.45M | 92K | 94K | 3.46M | 3.45M | 3.45M | 3.46M | 187K | 4.73M | 4.77M | 4.8M |
| Total Assets | 314.7M | 329.5M | 280.73M | 301.03M | 322.99M | 348.64M | 376.65M | 398.82M | 413.56M | 428.5M | 462.27M | 495.17M |
| Asset Turnover | 0.05x | 0.06x | 0.05x | 0.06x | 0.04x | 0.05x | 0.04x | 0.04x | 0.04x | 0.04x | 0.04x | 0.05x |
| Asset Growth % | -2.57% | -5.49% | -25.47% | -24.52% | -21.9% | -18.64% | -18.52% | -19.46% | 26.68% | 23.3% | 21.46% | 28.54% |
| Total Current Liabilities | 46.44M | 44.73M | 48.55M | 44.55M | 45.95M | 49.05M | 57.53M | 58.23M | 54.61M | 62.41M | 62.79M | 68.19M |
| Accounts Payable | 4.36M | 1.89M | 1.95M | 3.55M | 4.76M | 4.73M | 8M | 10.68M | 6.73M | 9.33M | 4.1M | 7.93M |
| Days Payables Outstanding | 232.56 | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 35.22M | 31.98M | 30.71M | 27.75M | 30.68M | 32.74M | 34.46M | 32.3M | 33.67M | 41.48M | 35.08M | 36.69M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 6.86M | 0 | 0 | 6.08M | 0 | 0 | 0 | 8.04M | 7.66M | 2.33M | 0 | 0 |
| Current Ratio | 3.84x | 4.44x | 4.21x | 5.00x | 5.29x | 5.47x | 5.21x | 4.92x | 6.43x | 6.25x | 6.73x | 6.58x |
| Quick Ratio | 3.84x | 4.44x | 4.21x | 5.00x | 5.29x | 5.47x | 5.21x | 4.92x | 6.43x | 6.25x | 6.73x | 6.58x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 151.67M | 158.18M | 167.46M | 177.2M | 183.51M | 187.78M | 190.3M | 191.68M | 192.84M | 174.21M | 182.75M | 189.16M |
| Long-Term Debt | 98.62M | 104.13M | 112.44M | 121.29M | 126.73M | 131.09M | 136.13M | 143.31M | 149.2M | 153.03M | 160.85M | 166.4M |
| Capital Lease Obligations | 52.78M | 53.78M | 54.76M | 55.66M | 56.54M | 56.45M | 53.94M | 48.14M | 43.41M | 20.52M | 21.24M | 22.33M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 278K | 269K | 260K | 252K | 243K | 235K | 231K | 227K | 224K | 649K | 663K | 426K |
| Total Liabilities | 198.12M | 202.91M | 216.01M | 221.75M | 229.46M | 236.83M | 247.84M | 249.91M | 247.44M | 236.62M | 245.54M | 257.35M |
| Total Debt | 186.62M | 193.18M | 201.06M | 207.1M | 216.14M | 221.29M | 226.06M | 226.17M | 229.86M | 220M | 222.44M | 230.8M |
| Net Debt | 151.69M | 155.75M | 168.76M | 162.29M | 155.93M | 136.94M | 188.82M | 190.4M | 166.32M | 180.07M | 137.05M | 135.62M |
| Debt / Equity | 1.60x | 1.53x | 3.11x | 2.61x | 2.31x | 1.98x | 1.75x | 1.52x | 1.38x | 1.15x | 1.03x | 0.97x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -3.57x | -2.86x | -6.82x | -10.26x | -12.97x | -10.57x | -10.31x | -8.79x | -11.30x | -8.89x | -8.37x | -16.45x |
| Total Equity | 116.59M | 126.59M | 64.72M | 79.28M | 93.54M | 111.82M | 128.81M | 148.91M | 166.11M | 191.88M | 216.74M | 237.82M |
| Equity Growth % | 24.64% | 13.21% | -49.76% | -46.76% | -43.69% | -41.73% | -40.57% | -37.38% | -38.33% | -36.22% | -32.55% | -29.64% |
| Book Value per Share | 4.04 | 5.92 | 3.03 | 3.72 | 4.38 | 5.26 | 6.08 | 7.03 | 7.85 | 9.10 | 10.29 | 11.30 |
| Total Shareholders' Equity | 116.59M | 126.59M | 64.72M | 79.28M | 93.54M | 111.82M | 128.81M | 148.91M | 166.11M | 191.88M | 216.74M | 237.82M |
| Common Stock | 291K | 290K | 214K | 214K | 214K | 213K | 212K | 212K | 212K | 212K | 211K | 210K |
| Retained Earnings | -429.96M | -416.87M | -404.93M | -386.23M | -367.97M | -345.33M | -323.04M | -294.22M | -271.56M | -240.4M | -207M | -178.89M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -734K | -329K | -339K | -402K | -224K | -29K | 302K | -653K | -667K | -534K | -1.17M | -1.5M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |